Current Studies

Our portfolio includes a variety of marketed drugs such as Opzelura, Skyrizi, Otezla, and Tremfya, as well as novel investigational drugs in various forms including topicals, oral medications, injectables, and IV therapies. We conduct phase 1 through 4 trials for conditions such as alopecia areata, atopic dermatitis (eczema), hidradenitis suppurativa, plaque psoriasis, chronic urticaria, vitiligo, prurigo nodularis, palmoplantar pustulosis (PPP), and more! We actively recruit both adults and children to participate in a variety of our studies.